Singapore: Sinovac Biotech, a provider of biopharmaceutical products in China, has appointed Mr Danny Chung as chief financial officer, with immediate effect.  Ms Nan Wang, who has served as interim chief financial officer since August 2011, will continue as the company's vice president. 

"Mr Chung possesses the relevant experiences and credentials, which meet the company's needs," said Dr Weidong Yin, chairman and CEO.  "Beyond his audit and accounting expertise, Mr Chung has proven adept in the financial management of Chinese divisions of multinational companies. We are pleased to welcome him to Sinovac," he added.

Mr Chung joined the company in November 2011 as Sinovac Beijing's finance director. He brings over 20 years of experience in audit and financial management to Sinovac. Mr Chung graduated in 1983 from the Hong Kong Polytechnic and obtained a Professional Diploma in Accountancy. He has held professional membership in the US Institute of Certified Public Accountants since 1990.